Literature DB >> 21209117

A comprehensive structure-function comparison of hepatitis C virus strain JFH1 and J6 polymerases reveals a key residue stimulating replication in cell culture across genotypes.

Melanie Schmitt1, Nathalie Scrima, Danijela Radujkovic, Célia Caillet-Saguy, Philip C Simister, Peter Friebe, Oliver Wicht, Rahel Klein, Ralf Bartenschlager, Volker Lohmann, Stéphane Bressanelli.   

Abstract

The hepatitis C virus (HCV) genotype 2a isolate JFH1 represents the only cloned HCV wild-type sequence capable of efficient replication in cell culture as well as in vivo. Previous reports have pointed to NS5B, the viral RNA-dependent RNA polymerase (RdRp), as a major determinant for efficient replication of this isolate. To understand the contribution of the JFH1 NS5B gene at the molecular level, we aimed at conferring JFH1 properties to NS5B from the closely related J6 isolate. We created intragenotypic chimeras in the NS5B regions of JFH1 and J6 and compared replication efficiency in cell culture and RdRp activity of the purified proteins in vitro, revealing more than three independent mechanisms conferring the role of JFH1 NS5B in efficient RNA replication. Most critical was residue I405 in the thumb domain of the polymerase, which strongly stimulated replication in cell culture by enhancing overall de novo RNA synthesis. A structural comparison of JFH1 and J6 at high resolution indicated a clear correlation of a closed-thumb conformation of the RdRp and the efficiency of the enzyme at de novo RNA synthesis, in accordance with the proposal that I405 enhances de novo initiation. In addition, we identified several residues enhancing replication independent of RdRp activity in vitro. The functional properties of JFH1 NS5B could be restored by a few single-nucleotide substitutions to the J6 isolate. Finally, we were able to enhance the replication efficiency of a genotype 1b isolate with the I405 mutation, indicating that this mechanism of action is conserved across genotypes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21209117      PMCID: PMC3067924          DOI: 10.1128/JVI.02177-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus.

Authors:  S Bressanelli; L Tomei; A Roussel; I Incitti; R L Vitale; M Mathieu; R De Francesco; F A Rey
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

2.  Refinement of macromolecular structures by the maximum-likelihood method.

Authors:  G N Murshudov; A A Vagin; E J Dodson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1997-05-01

3.  Crystal structure of the dengue virus RNA-dependent RNA polymerase catalytic domain at 1.85-angstrom resolution.

Authors:  Thai Leong Yap; Ting Xu; Yen-Liang Chen; Helene Malet; Marie-Pierre Egloff; Bruno Canard; Subhash G Vasudevan; Julien Lescar
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

4.  Production of infectious hepatitis C virus in tissue culture from a cloned viral genome.

Authors:  Takaji Wakita; Thomas Pietschmann; Takanobu Kato; Tomoko Date; Michiko Miyamoto; Zijiang Zhao; Krishna Murthy; Anja Habermann; Hans-Georg Kräusslich; Masashi Mizokami; Ralf Bartenschlager; T Jake Liang
Journal:  Nat Med       Date:  2005-06-12       Impact factor: 53.440

5.  PHENIX: a comprehensive Python-based system for macromolecular structure solution.

Authors:  Paul D Adams; Pavel V Afonine; Gábor Bunkóczi; Vincent B Chen; Ian W Davis; Nathaniel Echols; Jeffrey J Headd; Li-Wei Hung; Gary J Kapral; Ralf W Grosse-Kunstleve; Airlie J McCoy; Nigel W Moriarty; Robert Oeffner; Randy J Read; David C Richardson; Jane S Richardson; Thomas C Terwilliger; Peter H Zwart
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

6.  Internal ribosome entry site within hepatitis C virus RNA.

Authors:  K Tsukiyama-Kohara; N Iizuka; M Kohara; A Nomoto
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

7.  A novel sequence found at the 3' terminus of hepatitis C virus genome.

Authors:  T Tanaka; N Kato; M J Cho; K Shimotohno
Journal:  Biochem Biophys Res Commun       Date:  1995-10-13       Impact factor: 3.575

8.  Kissing-loop interaction in the 3' end of the hepatitis C virus genome essential for RNA replication.

Authors:  Peter Friebe; Julien Boudet; Jean-Pierre Simorre; Ralf Bartenschlager
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

9.  Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity.

Authors:  V Lohmann; F Körner; U Herian; R Bartenschlager
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

10.  Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees.

Authors:  Jens Bukh; Thomas Pietschmann; Volker Lohmann; Nicole Krieger; Kristina Faulk; Ronald E Engle; Sugantha Govindarajan; Max Shapiro; Marisa St Claire; Ralf Bartenschlager
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

View more
  30 in total

1.  Genotype and subtype profiling of PSI-7977 as a nucleotide inhibitor of hepatitis C virus.

Authors:  Angela M Lam; Christine Espiritu; Shalini Bansal; Holly M Micolochick Steuer; Congrong Niu; Veronique Zennou; Meg Keilman; Yuao Zhu; Shuiyun Lan; Michael J Otto; Phillip A Furman
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

2.  Hepatitis C virus nucleotide inhibitors PSI-352938 and PSI-353661 exhibit a novel mechanism of resistance requiring multiple mutations within replicon RNA.

Authors:  Angela M Lam; Christine Espiritu; Shalini Bansal; Holly M Micolochick Steuer; Veronique Zennou; Michael J Otto; Phillip A Furman
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

3.  Human leukocyte antigen B27 selects for rare escape mutations that significantly impair hepatitis C virus replication and require compensatory mutations.

Authors:  Christoph Neumann-Haefelin; Cesar Oniangue-Ndza; Thomas Kuntzen; Julia Schmidt; Katja Nitschke; John Sidney; Célia Caillet-Saguy; Marco Binder; Nadine Kersting; Michael W Kemper; Karen A Power; Susan Ingber; Laura L Reyor; Kelsey Hills-Evans; Arthur Y Kim; Georg M Lauer; Volker Lohmann; Alessandro Sette; Matthew R Henn; Stéphane Bressanelli; Robert Thimme; Todd M Allen
Journal:  Hepatology       Date:  2011-10       Impact factor: 17.425

4.  Construction of a chimeric hepatitis C virus replicon based on a strain isolated from a chronic hepatitis C patient.

Authors:  Huang Cao; Wandi Zhu; Qingxia Han; Rongjuan Pei; Xinwen Chen
Journal:  Virol Sin       Date:  2014-01-20       Impact factor: 4.327

Review 5.  BK polyomavirus diversity-Why viral variation matters.

Authors:  Jason T Blackard; Stella M Davies; Benjamin L Laskin
Journal:  Rev Med Virol       Date:  2020-03-03       Impact factor: 6.989

6.  Efficient infectious cell culture systems of the hepatitis C virus (HCV) prototype strains HCV-1 and H77.

Authors:  Yi-Ping Li; Santseharay Ramirez; Lotte Mikkelsen; Jens Bukh
Journal:  J Virol       Date:  2014-10-29       Impact factor: 5.103

7.  DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.

Authors:  Oliver Grünvogel; Katharina Esser-Nobis; Anna Reustle; Philipp Schult; Birthe Müller; Philippe Metz; Martin Trippler; Marc P Windisch; Michael Frese; Marco Binder; Oliver Fackler; Ralf Bartenschlager; Alessia Ruggieri; Volker Lohmann
Journal:  J Virol       Date:  2015-08-12       Impact factor: 5.103

8.  Low oxygen tension enhances hepatitis C virus replication.

Authors:  N Vassilaki; K I Kalliampakou; I Kotta-Loizou; C Befani; P Liakos; G Simos; A F Mentis; A Kalliaropoulos; P P Doumba; D Smirlis; P Foka; O Bauhofer; M Poenisch; M P Windisch; M E Lee; J Koskinas; R Bartenschlager; P Mavromara
Journal:  J Virol       Date:  2012-12-26       Impact factor: 5.103

9.  Robust full-length hepatitis C virus genotype 2a and 2b infectious cultures using mutations identified by a systematic approach applicable to patient strains.

Authors:  Yi-Ping Li; Santseharay Ramirez; Judith M Gottwein; Troels K H Scheel; Lotte Mikkelsen; Robert H Purcell; Jens Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-30       Impact factor: 11.205

10.  Two crucial early steps in RNA synthesis by the hepatitis C virus polymerase involve a dual role of residue 405.

Authors:  Nathalie Scrima; Célia Caillet-Saguy; Michel Ventura; Déborah Harrus; Thérèse Astier-Gin; Stéphane Bressanelli
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.